Gustavo Anderman Silva Barison

Gustavo Anderman Silva Barison

Auto-generated profile, based on publicly available information

Gustavo Anderman Silva Barison

Department of Gynecology and Obstetrics, Einstein Hospital Israelita, São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
BBBruna Bottura
Bruna Bottura
BPBeatriz Porto
Beatriz Porto
RMRenato Moretti-Marques
Renato Moretti-Marques
GBGustavo Barison²
Gustavo Barison²
EZEduardo Zlotnik²
Eduardo Zlotnik²
MGMariano Tamura Vieira Gomes²
Mariano Tamura Vieira Gomes²
Robotic surgery is currently on the rise and has been widely applied all over the world. Gynecology offers great opportunities for the development of innovative techniques due to the magnitude of surgical needs. The aim of this study was to correlate perioperative complications, surgical time, and length of hospital stay with surgical diagnosis, procedure performed, and surgeon experience in robot-assisted gynecological surgeries in a 10-year period. This was a retrospective, transversal, cross-sectional study involving 632 patients who underwent robotic gynecological surgery from January 2008 to December 2017 in a community hospital in Sao Paulo, Brazil. Medical records of robot-assisted gynecological operations were searched for perioperative complications, operative time, and length of hospital stay, correlating these outcomes with surgical diagnosis, procedure performed, and surgeon experience, considering those with 20 or less robotic procedures and surgeons with more than 20 cases in their career as in-training or qualified surgeons, respectively. Endometriosis (381 cases) was the most common surgical indication, followed by uterine myoma (171 patients). Qualified surgeons had 64% less complications than in-training surgeons (p=0.03) and achieved 20% lower surgical time and 15% shorter length of hospital stay. In this study, qualified surgeons with more than 20 robotic procedures had better perioperative outcomes and less complications than in-training surgeons during their first 20 robotic surgeries.

14 April 2022 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
GBGustavo Anderman Silva Barison
Gustavo Anderman Silva Barison
PDPaulo D’aMora
Paulo D’aMora
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
PDPaulo D'Amora
Paulo D'Amora
LMLuísa Marcella Martins
Luísa Marcella Martins
MGMariano Tamura Vieira Gomes
Mariano Tamura Vieira Gomes
Background Uterine leiomyomas are benign monoclonal tumors originating from the myometrium. Little information exists concerning metabolomics and the presence of leiomyomas. Objective The present study evaluated circulating metabolites in the plasma and their correlation with the presence and size of leiomyomas. Study Design Cross-sectional observational study, including women divided into 3 groups: 37 with leiomyomas and uterus >500 cm3, 17 with leiomyomas and uterus ≤150 cm3, and 21 leiomyoma-free. Patients underwent peripheral blood collection using untargeted metabolic assessment by gas chromatography coupled to mass spectrometer. Results There was no statistical difference between patients’ anthropometric and demographic features and laboratory tests. Statistical differences in uterus volume (P < 0.0001) were found. Forty-six metabolites were identified (35% amino acids and derivatives, 22% fatty acids, and 18% carbohydrates). Statistically significant metabolic distinction (P < 0.05, false discovery rate< 0.05) was observed for 14 metabolites. Most amino acids (L-isoleucine, L-valine, and pyroglutamic acid) were significantly reduced in plasma levels of patients with large leiomyomas. The only exception was L-glutamine, with a significant increase. Fatty acids (arachidonic acid, alfa-tocopherol, palmitic acid, and stearic acid) were similarly reduced in large leiomyomas patients, except for alpha-linolenic acid, which increased. For carbohydrates (myo-inositol, D-threitol, and D-ribose), there was a decrease in the plasma of patients with leiomyomas. Conclusion There are different plasma metabolites levels of amino acids, fatty acids, and carbohydrates among patients with leiomyomas, most of them reduced, but some significantly increased in large leiomyomas, compared to leiomyoma-free patients.

11 March 2026 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Open access
GAGiovanna Moreira Arcas
Giovanna Moreira Arcas
CLCarina Pita Lottenberg
Carina Pita Lottenberg
DMDebora Davalos Albuquerque Maranhao
Debora Davalos Albuquerque Maranhao
GBGustavo Anderman Silva Barison
Gustavo Anderman Silva Barison
To describe a safe and efficient approach for robotic myomectomy using the Hugo™ RAS system, emphasizing aesthetic trocar positioning, optimized hemostatic strategies, and precise uterine reconstruction in a fertility-preserving setting. Referral center (Einstein Hospital Israelita, São Paulo, Brazil), with active use of the Hugo™ RAS platform in gynecologic surgery. A 41-year-old nulliparous woman with abnormal uterine bleeding and infertility, desiring future fertility. Magnetic resonance imaging revealed an enlarged uterus (202 cm³) with multiple fibroids. The dominant lesion was a 5.5-cm FIGO type 2 anterior fibroid. Smaller fibroids did not distort the uterine cavity and were not removed to avoid unnecessary myometrial injury. Robotic myomectomy was performed using three robotic arms and standard laparoscopic trocars, as the system does not require proprietary ports. (1) The approach was selected based on favorable fibroid size and location. Although robotic assistance is not indispensable, it may facilitate precise multilayer suturing and effective hemostatic control in fertility-preserving surgery. Low abdominal port placement was adopted for improved cosmetic results, acknowledging that this configuration may not be suitable for larger uteri. Hemostasis included temporary bilateral uterine artery clipping and intramyometrial vasopressin injection. Monopolar and bipolar energy were used. Specimen extraction was performed transvaginally using a protective bag; alternative contained cold-scalpel morcellation techniques may be considered in selected nulliparous patients. Operative time was 122 minutes, with 50 mL estimated blood loss and no complications. (2) CONCLUSION: Robotic myomectomy with the Hugo™ RAS platform demonstrated feasible and safe performance in this selected case. There are currently no comparative studies supporting superiority over other robotic systems.

28 September 2026 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
MFMarina Quaglio Oinegue Fulfaro
Marina Quaglio Oinegue Fulfaro
TPTatiani Araujo Pandim
Tatiani Araujo Pandim
GBGustavo Anderman Silva Barison
Gustavo Anderman Silva Barison
PPPriscilla Duarte Pessoa
Priscilla Duarte Pessoa
GSGuilherme Albuquerque Sampaio
Guilherme Albuquerque Sampaio
MGMariano Tamura Vieira Gomes
Mariano Tamura Vieira Gomes